We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medicx Fund | LSE:MXF | London | Ordinary Share | GG00B1DVQL92 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 96.40 | 95.80 | 96.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMXF
RNS Number : 0754R
The MedicX Fund Limited
18 September 2017
For immediate release
18 September 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Securities allotted from Block Listing
MedicX Fund Limited (LSE: MXF), announces in accordance with Listing Rule 3.5.6R the number of securities allotted over the six month period pursuant to the block listing of 23,981,109 ordinary shares of no par value admitted to The Official List of the UK Listing Authority on 16 September 2016.
Name of applicant: MedicX Fund Limited ----------------------------------------------------------------------------------- --------------------------------- Name of scheme: Block Listing ----------------------------------------------------------------------------------- --------------------------------- Period of return: From: 19/03/2017 To: 18/09/2017 --------------------------------------------------------- ------------------------ ------------- ---- ------------ Balance of unallotted securities under scheme(s) from previous return: 18,500,217 ----------------------------------------------------------------------------------- --------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of 14 August 2017 - 14,771,668 the last return (if any increase has been applied for): ----------------------------------------------------------------------------------- --------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see 21/03/2017 - 2,000,000 LR3.5.7G): 04/04/2017 - 1,500,000 12/04/2017 - 1,500,000 13/04/2017 - 2,500,000 25/04/2017 - 500,000 26/04/2017 - 3,181,818 02/05/2017 - 1,500,000 03/05/2017 - 1,700,000 09/05/2017 - 1,850,000 18/05/2017 - 1,300,000 15/06/2017 - 968,399 Total allotted - 18,500,217 ----------------------------------------------------------------------------------- --------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: Total remaining - 14,771,668 ----------------------------------------------------------------------------------- --------------------------------- Name of contact: Alan Pennell ------------------------------ -------------- Telephone number of contact: 0203 142 4813 ------------------------------ --------------
- End -
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "the Fund" or "the Company", or together with its subsidiaries, "the Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1.1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers.
Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.
The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRKMGMLDRZGNZM
(END) Dow Jones Newswires
September 18, 2017 10:54 ET (14:54 GMT)
1 Year Medicx Chart |
1 Month Medicx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions